**Specifications table**TableSubject area*Cognitive Neuroscience*More specific subject area*Neurophysiology, Mismatch Negativity (MMN)*Type of data*Tables, Figure*How data was acquired*Electroencephalography (EEG), evoked potentials (ERPs)*Data format*Processed*Experimental factors*Two groups (schizophrenia patients, controls), temporal predictability of deviant stimuli (random/fixed)*Experimental features*Assessment of MMN, P3a and standard ERPs to 12% duration decrement deviant stimuli in 29 healthy controls and 31 schizophrenia patients. With a stimulus onset asynchronicity of 500 ms a deviant occurred every 4 seconds in the predictable condition while it varied randomly in the unpredictable condition.*Data source location*Essen, Germany*Data accessibility*Data are provided with this article*

**Value of the data** {#s0005}
=====================

•We report data on statistical analyses which may be of interest for other researchers when i.e. aiming to calculate sample sizes for future studies in this field of research.•We show an extended figure demonstrating how the mismatch negativity is generated by evoked response potential curves to standard and to deviant stimuli in the predictable and unpredictable deviance conditions.•We report data on ERP components to standard and deviant stimuli in patients and in controls which are not part of the MMN but which may be of specific interest for those doing evoked potential research in schizophrenia patients or other clinical samples.

1. Data {#s0010}
=======

The data give details of analyses of the dependent variable mismatch negativity (MMN) and other evoked response potential (ERP) components in relation to the experimental factors. We assessed two groups (patients with schizophrenia and controls) and used two experimental conditions (with and without predictability of the deviant stimulus). [Fig. 1](#f0005){ref-type="fig"} shows grand mean ERP curves to standard and deviant stimuli and the resulting MMN difference wave in both groups and both conditions ([Table 1](#t0005){ref-type="table"}, [Table 2](#t0010){ref-type="table"}, [Table 3](#t0015){ref-type="table"}, [Table 4](#t0020){ref-type="table"}, [Table 5](#t0025){ref-type="table"}, [Table 6](#t0030){ref-type="table"}, [Table 7](#t0035){ref-type="table"}, [Table 8](#t0040){ref-type="table"}, [Table 9](#t0045){ref-type="table"}, [Table 10](#t0050){ref-type="table"}, [Table 11](#t0055){ref-type="table"}, [Table 12](#t0060){ref-type="table"}).Fig. 1Grand mean evoked response potential curves to standard and deviant stimuli and mismatch negativity (MMN) difference waves in two conditions (predictable & unpredictable) and two groups (patients & controls) at electrode Fz (µV).Fig. 1Table 1MANOVA MMN mean amplitude 2 group (between factor patient/control)×2 predictability (within factor fixed/random) analysis of variance.Table 1.1:*F*DfSigMain effect group1.6511/58.204Main effect predictability4.7971/58.033Interaction group×predictability4.0871/58.048Table 2*T*-tests on the effect of group (patient/control) on MMN amplitudes in (a) in the predictable condition and (b) in the unpredictable condition.Table 1.2.:*T*DfSig(a) Predictable group1.5158.880(b) Unpredictable group−2.3258.023Table 3MMN mean amplitudes in a predictability (within factor: fixed/random) analysis of variance (a) in controls and (b) in patients with schizophrenia.Table 1.3.:*F*DfSig(a) Within effect predictability controls0.0181/28.894(b) Within effect predictability patients7.5381/30.010Table 4Pearson correlation between **control subjects** general and cognition variable and mean MMN amplitudes in fixed and random condition and fixed-random difference score (*p*\<.01 in bold).Table 2.1.:Pearson correlationMMN mean amplitude fixed (*r*, sign.)MMN mean amplitude random (*r*, sig)MMN mean amplitude random−fixed difference score (*r*, sig)**Control subjects**Age (yrs).1.6 (*p*=.39)−.29 (*p*=.11)−.39 (*p*=.03)Education (yrs)−.05 (*p*=.67)−.28 (*p*=.13)−.19 (*p*=.13)MWT-B (IQ score)−.10 (*p*=.58)−.40 (*p*=.02)−.24 (*p*=.21)Table 5Pearson correlation between **schizophrenia patients** general, clinical and cognition variables and mean MMN amplitudes in fixed and random condition and fixed-random difference score.Table 2.2.:Pearson correlation**MMN mean amplitude fixed** (*r*, sig)**MMN mean amplitude random** (*r*, sig)**MMN mean amplitude random−fixed difference score** (*r*, sig)**Schizophrenia patients**Age (yrs).17 (*p*=.34)−.01 (*p*=.92)−.16 (*p*=.37)Education (yrs).05 (*p*=.76)−.25 (*p*=.17)−.25 (*p*=.17)MWT-B (IQ score).31 (*p*=.08).11 (*p*=.52)−.17 (*p*=.34)**Clinical**Schizophrenia onset (age).12 (*p*=.52)−.10 (*p*=.57)−.18 (*p*=.31)Schizophrenia duration (yrs).12 (*p*=.51).07 (*p*=.67)−.04 (*p*=.82)PANSS positive (score)−.07 (*p*=.70)−.03 (*p*=.85).03 (*p*=.85)PANSS negative (score).01 (*p*=.97).01 (*p*=.92).01 (*p*=.96)PANSS global (score)−.09 (*p*=.59).06 (*p*=.72).13 (*p*=.45)PANSS total (score)−.06 (*p*=.71).02 (*p*=.88).07 (*p*=.67)GAF (score)−.16 (*p*=.38)−.32 (*p*=.07)−.11 (*p*=.52)Table 6P3a component amplitude data derived from the difference wave (mean, sd \[µV\]).Table 4.1:P3a Fz amplitudesPatient \[mean (sd) µV\]Control \[mean (sd )µV\]Unpredictable0.41 (1.73)−0.16 (1.55)Predictable−0.38 (1.84)0.30 (1.27)Table 7MANOVA on P3a amplitudes: 2 group (between factor patient/control)×2 predictability (within factor fixed/random) multivariate analysis of variance.Table 4.2:*F*DfSigMain effect group0.031/58.875Main effect predictability0.431/58.512**Interaction group**×**predictability6.25**1/58**.015**Table 8MANOVA on P3a amplitudes: within factor predictability (fixed/random) analysis of variance in each group (patient/control) separately.Table 4.3:*F*DfSigEffect of predictability controls2.281/28.142Effect of predictability patients4.081/30.052Table 9*T*-tests P3a amplitudes: effect of group (patient/control) within each condition (predictable/unpredictable).Table 4.4:*T*DfSigPredictable1.6753.6.103Unpredictable−1.3558.182Table 10P50, N100, and P200 ERP data to standard and deviant stimuli: amplitude (µV) and latency (ms) data.Table 5.1.**Patient (mean (sd))Control (mean (sd))Amplitudes (µV)**STD P50 fixed2.21 (1.23)2.03 (1.06)STD P50 random2.12 (1.04)2.17 (0.99)STD N100 fixed−0.74 (1.51)−1.12 (1.48)STD N100 random−0.49 (1.26)−0.85 (1.62)STD P200 fixed2.03 (1.39)1.43 (1.13)STD P200 random1.81 (1.13)1.63 (1.10)DEV P50 fixed1.87 (1.60)1.93 (1.18)DEV P50 random2.37 (1.85)2.04 (1.12)**Latencies (ms)**STD P50 fixed76.58 (11.03)74.00 (14.66)STD P50 random77.29 (10.26)76.55 (11.99)STD N100 fixed127.81 (17.32)124.34 (12.73STD N100 random129.16 (13.29)127.93 (14.74)STD P200 fixed183.10 (26.60)172.55 (19.38)STD P200 random178.90 (26.32)174.76 (19.37)DEV P50 fixed72.58 (12.43)73.10 (11.62)DEV P50 random78.90 (13.31)73.31 (15.52)Table 11MANOVA analyses of ERP components to standard stimuli (STD) and to deviant stimuli (DEV). Group (patient/control)×predictability (random/fixed) analyses.Table 5.2:MANOVAMain effect group (patient/control)Main effect predictability (fixed/random)Interaction group×predictability*F*DfSig*F*DfSig*F*DfSigAmp.P50 STD0.051/58.8230.051/58.8190.941/58.335N100 STD1.051/58.309**4.531**/**58.038**0.011/58.929P200 STD1.981/58.1650.011/58.9102.261/58.139Lat.P50 STD0.341/58.5651.821/58.1820.581/58.449N100 STD0.491/58.4851.901/58.1730.391/58.536P200 STD2.051/58.1570.101/58.7541.031/58.315Table 12MANOVA analysis on P50 data to standard and deviant stimuli in a group (patient/control)×predictability (fixed/random)×stimulus (P50 to standards, P50 to deviants) analysis.Table 5.3:P50 group×predictability×stimulus*F*DfSigMain effect group (patient/control)0.121/58.734Main effect stimulus (standard/deviant)2.141/58.149Main effect predictability (fixed/random)0.591/58.446Interaction group×predictability0.111/58.739Interaction predictability×stimulus1.281/58.263Interaction stimulus×group0.131/58.718Interaction predictability×stimulus×group1.601/58.212

2. Experimental design, materials and methods {#s0015}
=============================================

We assessed 31 patients with schizophrenia and 29 control subjects. Groups did not differ in years in education, amount of smokers and a proxy of verbal IQ (MWT-B) [@bib5]. Exclusion criteria were age exceeding 18--55 yrs, alcohol or drug abuse or dependency or past dependencies less than 1 year ago, acute neurological or DSM-IV axis-I disorders other than schizophrenia or schizoaffective disorder and current benzodiazepine medication.

2.1. Clinical assessments {#s0020}
-------------------------

Diagnoses were verified by means of Structured Clinical Interview for DSM**-**IV (SCID)[@bib7] in patients and short diagnostic interviews for DSM-IV diagnoses in controls (Mini-DIPS) [@bib6]. Clinical symptom assessments comprised the Positive and Negative Syndrome Scale (PANSS) [@bib4] and the Global Assessment of Functioning Scale (GAF) [@bib1].

2.2. Stimuli and experimental design {#s0025}
------------------------------------

Auditory stimuli presented with a 500 ms stimulus onset asynchrony. Sine-wave tones were 1 kHz, 80 dBA and 80 ms with rise and fall times of 10 ms. Deviant tones had a duration of 40 ms with 5 ms rise/fall time. Deviant probability was 12% in both conditions. In the fixed predictable condition the fourth stimulus was a duration deviant stimulus \"D\", the other stimuli were standards \"S\" resulting in a series of \"SSSDSSSS\" stimuli. In the unpredictable random condition, the duration deviant stimulus occurred randomly at the second to eight position in the train of eight stimuli. No deviants occurred in direct succession. Stimuli were presented in two runs using \"Presentation\" (V.14.1, Neurobehavioral Systems Inc.) software while participants watched a silent nature film (visual angle 5°).

2.3. EEG recording and analysis {#s0030}
-------------------------------

EEG was recorded at Fz, Fcz, Cz, C3 and C4. Linked earlobes were used as reference and AFz as ground. EOG was recorded to monitor vertical and horizontal eye movements. EEG was recorded with a band pass filter of 1.5--250 Hz and a digitisation rate of 500 Hz. Trials with artefacts were excluded and data were passed through an IIR Butterworth zero 30 Hz low pass filter (48 dB/oct) [@bib2]. Eye blinks were corrected using a regression method [@bib3]. Segments were computed from 100 ms before to 400 ms after stimulus onset and baseline-corrected. Epochs exceeding ±50 µV were rejected from further analysis. Single subject averages were computed for stimulus types and conditions. MMN difference waves were obtained and peak amplitudes and latencies were determined at electrode site Fz, which showed the largest MMN amplitude in this study. MMN mean amplitudes comprising data points ±50 ms around individual peak amplitudes were computed. P3a was assessed from MMN difference curves for the largest positive deflection following the MMN. Additionally, we measured amplitudes and latencies of standard ERP components P50, N100 and P200 in ERP average waveforms to standard stimuli and the P50 component from ERP average waveforms to deviant stimuli.

Appendix A. Supplementary material {#s0045}
==================================

Supplementary material
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Supplementary data associated with this article can be found in the online version at [doi:10.1016/j.dib.2016.03.045](http://dx.doi.org/10.1016/j.dib.2016.03.045){#ir0005}.
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